Published in Nat Biotechnol on March 16, 2014
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design. Immunity (2015) 1.66
Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows. Nature (2017) 1.38
Characterizing immune repertoires by high throughput sequencing: strategies and applications. Trends Immunol (2014) 1.03
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity. J Virol (2015) 1.01
Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos. Sci Rep (2015) 0.93
CRISPR-Cas9-mediated genome editing and guide RNA design. Mamm Genome (2015) 0.84
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice. Science (2016) 0.84
Antibody humanization by structure-based computational protein design. MAbs (2015) 0.80
Human antibody production in transgenic animals. Arch Immunol Ther Exp (Warsz) (2014) 0.79
HIV-1 Env-specific memory and germinal center B cells in C57BL/6 mice. Viruses (2014) 0.77
Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies. Immunol Rev (2017) 0.76
Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody. MAbs (2015) 0.76
Computationally driven antibody engineering enables simultaneous humanization and thermostabilization. Protein Eng Des Sel (2016) 0.76
New models of human immunity. Nat Biotechnol (2014) 0.75
Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses. J Biol Chem (2016) 0.75
Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals. Sci Rep (2017) 0.75
Molecular and clinical implementations of ovarian cancer mouse avatar models. Chin Clin Oncol (2015) 0.75
Expression Cloning and Production of Human Heavy-Chain-Only Antibodies from Murine Transgenic Plasma Cells. Front Immunol (2016) 0.75
Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRn. MAbs (2017) 0.75
The contribution of homology arms to nuclease-assisted genome engineering. Nucleic Acids Res (2017) 0.75